Literature DB >> 23776152

Hyperphagia among patients with Bardet-Biedl syndrome.

R Sherafat-Kazemzadeh1, L Ivey, S R Kahn, J C Sapp, M D Hicks, R C Kim, A J Krause, L B Shomaker, L G Biesecker, J C Han, J A Yanovski.   

Abstract

BACKGROUND: The importance of hyperphagia as a cause for energy imbalance in humans with Bardet-Biedl syndrome (BBS) has not been established. We therefore compared hyperphagic symptoms in patients with BBS vs. controls.
METHODS: We studied 13 patients with BBS and 23 non-syndromic controls with similar age, sex and body mass index (BMI) z-score. A 13-item hyperphagia questionnaire was completed by patients' parents/guardians.
RESULTS: Total hyperphagia questionnaire score was higher in BBS than controls (27.6 ± 9.0 vs. 19.1 ± 7.9, P = 0.005). Behaviour and drive subscales were higher for BBS than controls (12.5 ± 4.1 vs. 7.8 ± 3.2, P = 0.001, and 11.2 ± 4.1 vs. 8.3 ± 3.8, P = 0.04, respectively); severity was not significantly different between groups (3.8 ± 1.5 vs. 3.0 ± 1.3, P = 0.072). After adjustment for demographic variables and BMI z-score, total and behaviour subscale scores remained significantly different between groups, suggesting food-seeking activity, rather than preoccupation with food may be the main hyperphagic feature among patients with BBS.
CONCLUSION: Appetite dysregulation may contribute to obesity in BBS.
© 2013 The Authors. Pediatric Obesity © 2013 International Association for the Study of Obesity.

Entities:  

Keywords:  Bardet-Biedl syndrome; hyperphagia; obesity syndromes; polyphagia

Mesh:

Year:  2013        PMID: 23776152      PMCID: PMC3901011          DOI: 10.1111/j.2047-6310.2013.00182.x

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   4.000


  19 in total

1.  Bardet-Biedl syndrome.

Authors:  P K Hrynchak
Journal:  Optom Vis Sci       Date:  2000-05       Impact factor: 1.973

2.  Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study.

Authors:  Susan J Moore; Jane S Green; Yanli Fan; Ashvinder K Bhogal; Elizabeth Dicks; Bridget A Fernandez; Mark Stefanelli; Christopher Murphy; Benvon C Cramer; John C S Dean; Philip L Beales; Nicholas Katsanis; Anne S Bassett; William S Davidson; Patrick S Parfrey
Journal:  Am J Med Genet A       Date:  2005-02-01       Impact factor: 2.802

3.  A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.

Authors:  Giles S H Yeo; Chiao-Chien Connie Hung; Justin Rochford; Julia Keogh; Juliette Gray; Shoba Sivaramakrishnan; Stephen O'Rahilly; I Sadaf Farooqi
Journal:  Nat Neurosci       Date:  2004-10-24       Impact factor: 24.884

4.  Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone.

Authors:  W B Zipf; G G Berntson
Journal:  Am J Clin Nutr       Date:  1987-08       Impact factor: 7.045

5.  Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome.

Authors:  A J Holland; J Treasure; P Coskeran; J Dallow; N Milton; E Hillhouse
Journal:  Int J Obes Relat Metab Disord       Date:  1993-09

6.  Energy metabolism in Bardet-Biedl syndrome.

Authors:  C Grace; P Beales; C Summerbell; S A Jebb; A Wright; D Parker; P Kopelman
Journal:  Int J Obes Relat Metab Disord       Date:  2003-11

7.  Phenotypic expression of Bardet-Biedl syndrome in patients homozygous for the common M390R mutation in the BBS1 gene.

Authors:  Kyle F Cox; Natalie C Kerr; Marina Kedrov; Darryl Nishimura; Barbara J Jennings; Edwin M Stone; Val C Sheffield; Alessandro Iannaccone
Journal:  Vision Res       Date:  2012-08-24       Impact factor: 1.886

8.  Assessment of hyperphagia in Prader-Willi syndrome.

Authors:  Elisabeth M Dykens; Melissa A Maxwell; Elizabeth Pantino; Rebecca Kossler; Elizabeth Roof
Journal:  Obesity (Silver Spring)       Date:  2007-07       Impact factor: 5.002

9.  Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene.

Authors:  Juliette Gray; Giles S H Yeo; James J Cox; Jenny Morton; Anna-Lynne R Adlam; Julia M Keogh; Jack A Yanovski; Areeg El Gharbawy; Joan C Han; Y C Loraine Tung; John R Hodges; F Lucy Raymond; Stephen O'rahilly; I Sadaf Farooqi
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 10.  The ciliopathies: an emerging class of human genetic disorders.

Authors:  Jose L Badano; Norimasa Mitsuma; Phil L Beales; Nicholas Katsanis
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

View more
  10 in total

Review 1.  Primary cilia in pancreatic development and disease.

Authors:  Sukanya Lodh; Elizabeth A O'Hare; Norann A Zaghloul
Journal:  Birth Defects Res C Embryo Today       Date:  2014-05-26

2.  Differentiation of hypothalamic-like neurons from human pluripotent stem cells.

Authors:  Liheng Wang; Kana Meece; Damian J Williams; Kinyui Alice Lo; Matthew Zimmer; Garrett Heinrich; Jayne Martin Carli; Charles A Leduc; Lei Sun; Lori M Zeltser; Matthew Freeby; Robin Goland; Stephen H Tsang; Sharon L Wardlaw; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

3.  Comprehensive Endocrine-Metabolic Evaluation of Patients With Alström Syndrome Compared With BMI-Matched Controls.

Authors:  Joan C Han; Daniela P Reyes-Capo; Chia-Ying Liu; James C Reynolds; Evrim Turkbey; Ismail Baris Turkbey; Joy Bryant; Jan D Marshall; Jürgen K Naggert; William A Gahl; Jack A Yanovski; Meral Gunay-Aygun
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

4.  Pathways to eating in children and adolescents with obesity.

Authors:  Hayyah Clairman; Elizabeth Dettmer; Annick Buchholz; Kristina Cordeiro; Quazi Ibrahim; Katerina Maximova; Alene Toulany; Valerie H Taylor; Debra K Katzman; Katherine M Morrison; Jill Hamilton; Geoff Ball; Jean-Pierre Chanoine; Josephine Ho; Laurent Legault; Pam Mackie; Lehana Thabane; Ian Zenlea
Journal:  Int J Obes (Lond)       Date:  2018-12-19       Impact factor: 5.095

5.  The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design.

Authors:  Robert M Haws; Gregory Gordon; Joan C Han; Jack A Yanovski; Guojun Yuan; Murray W Stewart
Journal:  Contemp Clin Trials Commun       Date:  2021-05-03

6.  The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function.

Authors:  Jayne F Martin Carli; Charles A LeDuc; Yiying Zhang; George Stratigopoulos; Rudolph L Leibel
Journal:  FASEB J       Date:  2018-02-21       Impact factor: 5.834

7.  Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.

Authors:  Robert Haws; Sheila Brady; Elisabeth Davis; Kristina Fletty; Guojun Yuan; Gregory Gordon; Murray Stewart; Jack Yanovski
Journal:  Diabetes Obes Metab       Date:  2020-07-22       Impact factor: 6.577

8.  Correction of cilia structure and function alleviates multi-organ pathology in Bardet-Biedl syndrome mice.

Authors:  Hervé Husson; Nikolay O Bukanov; Sarah Moreno; Mandy M Smith; Brenda Richards; Cheng Zhu; Tyler Picariello; Hyejung Park; Bing Wang; Thomas A Natoli; Laurie A Smith; Stefano Zanotti; Ryan J Russo; Stephen L Madden; Katherine W Klinger; Vijay Modur; Oxana Ibraghimov-Beskrovnaya
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

Review 9.  Childhood obesity and the associated rise in cardiometabolic complications.

Authors:  Sonia Caprio; Nicola Santoro; Ram Weiss
Journal:  Nat Metab       Date:  2020-03-16

10.  Neuron-specific cilia loss differentially alters locomotor responses to amphetamine in mice.

Authors:  Carlos Ramos; Jonté B Roberts; Kalene R Jasso; Tyler W Ten Eyck; Thomas Everett; Patricia Pozo; Barry Setlow; Jeremy C McIntyre
Journal:  J Neurosci Res       Date:  2020-11-11       Impact factor: 4.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.